Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

New England Journal of Medicine

Volumn 337, Issue 17, 1997, Pages 1181-1187

  Pérez Schael, Irene ^a   Guntiñas, María J ^a   Pérez, Mireya ^a   Pagone, Vito ^a   Rojas, Ana M ^a   González, Rosabel ^a   Cunto, Walter ^a   Hoshino, Yasutaka ^b   Kapikian, Albert Z ^b  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ORAL POLIOMYELITIS VACCINE; SIMIAN ROTAVIRUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INFANT; INFANTILE DIARRHEA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROTAVIRUS; VACCINATION; VENEZUELA;

ANTIBODIES, VIRAL; DEHYDRATION; DEVELOPING COUNTRIES; DIARRHEA, INFANTILE; DISEASE TRANSMISSION, HORIZONTAL; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VENEZUELA; VIRAL VACCINES;

EID: 1842409544     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710233371701     Document Type: Article

References (40)

1. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J Infect Dis 1996;174:Suppl 1:S65-S72.
2. Glass RI, Gentsch JR, Smith JC. Rotavirus vaccines: success by reassortment? Science 1994;265:1389-91.
3. Prospects for immunizing against rotavirus. In: Institute of Medicine. New vaccine development: establishing priorities. Vol. 1. Diseases of importance in the United States. Washington, D.C.: National Academy Press, 1985:410-23.
4. The prospects for immunizing against rotavirus. In: Institute of Medicine. New vaccine development: establishing priorities. Vol. 2. Diseases of importance in developing countries. Washington, D.C.: National Academy Press, 1986:308-18.
5. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 1995;273:1191-6.
6. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the National Multicenter Trial. Pediatrics 1996;97:7-13.
7. Vesikari T. Clinical experience with rotavirus vaccine in Finland. Presented at the 2nd Satellite Symposium of the 14th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Elsinore, Denmark, 18-21 June 1996.
8. Lanata CF, Midthun K, Black RE, et al. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 1996;174:268-75.
9. Linhares AC, Gabbay YB, Mascarenhas JDP, et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 1996;74:491-500.
10. Mendez-Castellano H, De Mendez MC. Estratificacion social y biologia humana: Metodo Graffar modificado. Arch Venez Pueric Pediatr 1986; 49:93-104.
11. Morris SS, Cousens SN, Lanata CF, Kirkwood BR. Diarrhoea - defining the episode. Int J Epidemiol 1994;23:617-23.
12. A manual for the treatment of diarrhoea: for use by physicians and other senior health workers. Geneva: World Health Organization, 1990.
13. Kapikian AZ, Yolken RH, Greenberg HB, et al. Gastroenteritis viruses. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. Washington, D.C.: American Public Health Association, 1979:927-95.
14. Brandt CD, Kim HW, Rodriguez WJ, et al. Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol 1981;13:976-81.
15. Taniguchi K, Urasawa T, Morita Y, Greenberg HB, Urasawa S. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis 1987;155:1159-66.
16. Shaw RD, Stoner-Ma DL, Estes MK, Greenberg HB. Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol 1985; 22:286-91.
17. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28:276-82.
18. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994;32: 1820-2.
19. Kalica AR, Sereno MM, Wyatt RG, Mebus CA, Chanock RM, Kapikian AZ. Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. Virology 1978;87:247-55.
20. Flores J, Greenberg HB, Myslinski J, et al. Use of transcription probes for genotyping rotavirus reassortants. Virology 1982;121:288-95.
21. Henriksen SA, Pohlenz JF. Staining of cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet Scand 1981;22:594-6.
22. Kelly MT, Brenner DJ, Farmer JJ III. Enterobacteriaceae. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:263-76.
23. Day NP, Scotland SM, Rowe B. Comparison of an HEp-2 tissue culture test with the Sereny test for detection of enteroinvasiveness in Shigella spp. and Escherichia coli. J Clin Microbiol 1981;13:596-7.
24. Cravioto A, Gross RJ, Scotland SM, Rowe B. An adhesive factor found in strains of Escherichia coli belonging to the traditional enteropathogenic serotypes. Curr Microbiol 1979;3:95-9.
25. Orskov F, Orskov I. Serotyping of Eschcrichia coli. In: Bergen E, ed. Methods in microbiology. London: Academic Press, 1984:43-112.
26. Losonsky GA, Rennels MB, Lim Y, Krall G, Kapikian AZ, Levine MM. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. Pediatr Infect Dis J 1988;7:388-93.
27. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis 1984;149:694-702.
28. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990;22:259-67.
29. Perez-Schael I, Garcia D, Gonzalez M, et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 1990;30:219-29.
30. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-68.
31. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N Engl J Med 1983;309:72-6.
32. Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996;335: 1022-8.
33. Perez-Schael I. The impact of rotavirus disease in Venezuela. J Infect Dis 1996;174:Suppl 1:S19-S21.
34. Gonzalez R, Diaz C, Marino M, Cloralt R, Pequeneze M, Perez-Schael I. Age-specific prevalence of Escherichia coli with localized and aggregative adherence in Venezuelan infants with acute diarrhea. J Clin Microbiol 1997;35:1103-7.
35. Rojas AM, Boher Y, Guntinas MJ, Perez-Schael I. Homotypic immune response to primary infection with rotavirus serotype Gl. J Med Virol 1995;47:404-9.
36. Green KY, Taniguchi K, Mackow ER, Kapikian AZ. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis 1990;161: 667-79.
37. Perez-Schael I, Blanco M, Vilar M, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28: 553-8.
38. Flores J, Perez-Schael I, Blanco M, et al. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol 1993;31:2439-45.
39. Perez-Schael I, Blanco M, Garcia D, et al. Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates. J Med Virol 1994; 42:330-7.
40. Hoshino Y, Kapikian AZ. Classification of rotavirus VP4 and VP7 serotypes. Arch Virol Suppl 1996;12:99-111.